| Li, Debiao |
Cedars-Sinai Medical Center
United States |
Predicting Pancreatic Ductal Adenocarcinoma (PDAC) Through Artificial Intelligence Analysis of Pre-Diagnostic CT Images |
5R01CA260955-03 |
|
Matthew Young, Ph.D. |
| Li, Debiao |
Cedars-Sinai Medical Center
United States |
Predicting Pancreatic Ductal Adenocarcinoma (PDAC) Through Artificial Intelligence Analysis of Pre-Diagnostic CT Images |
5R01CA260955-03 |
|
Matthew Young, Ph.D. |
| Li, Debiao |
Cedars-Sinai Medical Center
United States |
Predicting Pancreatic Ductal Adenocarcinoma (PDAC) Through Artificial Intelligence Analysis of Pre-Diagnostic CT Images |
5R01CA260955-03 |
|
Matthew Young, Ph.D. |
| Valdimarsdottir, Heiddis |
Icahn School Of Medicine At Mount Sinai
United States |
Systematic Light Exposure Effects on Circadian Rhythms Entrainment, Inflammation, Neutropenic Fever and Symptom Burden among Multiple Myeloma Patients undergoing Autologous Stem Cell Transplantation |
5R01CA260961-02 |
PAR-21-035 (R01 Clinical Trial Required) |
Marge Good, R.N., M.P.H., O.C.N. |
| Kroetz, Deanna L |
Ohio State University
United States |
Sphingolipid Signaling and Chemotherapy-Induced Peripheral Neurotoxicity |
5R01CA261068-05 |
|
Rachel Altshuler, Ph.D. |
| Yeh, Jennifer M. |
Boston Children'S Hospital
United States |
Can risk-reducing medications improve breast cancer prevention in childhood and adolescent cancer survivors? Comparative modeling to inform care |
5R01CA261874-02 |
|
Eileen Dimond, R.N., M.S. |
| Salvemini, Daniela |
Saint Louis University
United States |
Fingolimod and Ozanimod for the treatment and prevention of chemobrain |
5R01CA261979-02 |
|
Rachel Altshuler, Ph.D. |
| Huberty, Jennifer Lynne |
University Of Texas Hlth Science Center
United States |
Consumer-based meditation app, Calm, for treatment of sleep disturbance in hematological cancer patients |
5R01CA262041-04 |
|
Marge Good, R.N., M.P.H., O.C.N. |
| Skubitz, Amy Patrice |
University Of Minnesota
United States |
A paradigm shift for ovarian cancer biomarkers: Utilizing routine Pap tests as liquid biopsies for the development of targeted mass spectrometry-based proteomic assays for early detection |
5R01CA262153-03 |
PA-20-185 (Parent R01 Clinical Trial Not Allowed) |
Christos Patriotis, Ph.D., M.Sc. |
| Robbins, Hilary A. |
International Agency For Res On Cancer
United States |
The Lung EArly Proteins project: A LEAP toward implementing biomarkers in lung cancer screening |
5R01CA262164-02 |
|
Claire Zhu, Ph.D. |